INCYTE CORPORATION Unrecognized Tax Benefits, Period Increase (Decrease)
INCYTE CORPORATION (INCY) reported Unrecognized Tax Benefits, Period Increase (Decrease) of $22.50 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-29.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease · last filed 2024-10-29
- INCYTE CORPORATION unrecognized tax benefits, period increase (decrease) for the quarter ending 2024-09-30 was $3.20M.
- INCYTE CORPORATION unrecognized tax benefits, period increase (decrease) for the quarter ending 2024-06-30 was $15.10M.
- INCYTE CORPORATION unrecognized tax benefits, period increase (decrease) for the quarter ending 2024-03-31 was $4.20M, a 55.56% increase year-over-year.
- INCYTE CORPORATION unrecognized tax benefits, period increase (decrease) for the quarter ending 2023-03-31 was $2.70M, a 57.14% decline year-over-year.
| Period end | Unrecognized Tax Benefits, Period Increase (Decrease) 3 month | Unrecognized Tax Benefits, Period Increase (Decrease) 6 month | Unrecognized Tax Benefits, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2024-09-30 | $3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $18.30M derived: sum of 2 quarters · filed 2024-10-29 | $22.50M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $15.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $19.30M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $4.20M 10-Q · filed 2024-04-30 | ||
| 2023-09-30 | -$2.10M 10-Q · filed 2023-10-31 | ||
| 2023-03-31 | $2.70M 10-Q · filed 2023-05-02 | ||
| 2022-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $4.90M derived: sum of 2 quarters · filed 2022-11-01 | $11.20M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $9.40M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $6.30M 10-Q · filed 2022-05-03 | ||
| 2021-09-30 | $5.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $6.40M derived: sum of 2 quarters · filed 2021-11-02 | $7.30M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $1.70M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $900.00K 10-Q · filed 2021-05-04 | ||
| 2020-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.40M derived: sum of 2 quarters · filed 2020-11-05 | $1.50M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $800.00K 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $100.00K 10-Q · filed 2020-05-05 | ||
| 2019-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $1.40M derived: sum of 2 quarters · filed 2019-10-29 | $1.80M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $900.00K 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $400.00K 10-Q · filed 2019-04-30 | ||
| 2018-09-30 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $4.60M derived: sum of 2 quarters · filed 2018-10-30 | $5.90M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $2.40M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $1.30M 10-Q · filed 2018-05-01 | ||
| 2017-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $2.90M derived: sum of 2 quarters · filed 2017-10-31 | $3.60M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $1.60M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $700.00K 10-Q · filed 2017-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |